KATHRYN SPENCER: Open Payments
NPI 1457070625 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,542 in 82 payments from 8 companies in 2025. Trend: 2023 $952 · 2024 $8,490 · 2025 $8,542
Speaker / faculty: $5,652Food & beverage: $1,688Travel & lodging: $1,131Education: $71
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 29 | $7,563 |
| Neurocrine BioSciences, Inc. | 12 | $267 |
| Alkermes, Inc. | 13 | $250 |
| Janssen Pharmaceuticals, Inc | 11 | $189 |
| E.R. Squibb & Sons, L.L.C. | 10 | $162 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
Products named: UZEDY, INGREZZA, ARISTADA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, FANAPT, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
